|
Mr. Liebler joined Pharmacopeia in September of 2007. Prior to joining Pharmacopeia, Mr. Liebler was Senior Vice President of Strategic Planning and Communications for Questcor Pharmaceuticals and the founder of Nisola, LLC, a provider of management financial and investor services to CNS-focused specialty and biotechnology companies. Mr. Liebler spent over ten years with Elan Corporation and its predecessor, Athena Neurosciences, where he served in a number of increasingly senior roles in Marketing, Investor Relations and Strategic Planning. Mr. Liebler served as President of Amarin Pharmaceuticals, a CNS-focused specialty pharmaceutical company and as Vice President of Business Development for Enzon Pharmaceuticals. Mr. Liebler started his career in PaineWebber�s (now UBS) Health Care investment banking group. Mr. Liebler currently serves as a public trustee and Vice Chairman of the American Academy of Neurology Foundation.
| 